| Fucoidananticancer, antiviral, neuroprotective, immune-modulating |
Sample solution is provided at 25 µL, 10mM.
Nature.2017 Jan 19;541(7637):417-420.
Nature.2018 Nov;563(7731):407-411.Nature.2018 Jun 13.Nature.2018 Jun 27.Nature.2018 Mar 29;555(7698):673-677.Nature.2017 Sep 7;549(7670):96-100.Nature.2016 Apr 21;532(7599):398-401.
Science.2016 Aug 5;353(6299)594-8Nat Nanotechnol.2017 Dec;12(12):1190-1198.Nature Biotechnology.2017 Jun;35(6):569-576Nat Med.2018 Sep 17.Cell.2018 Dec 21. pii: S0092-8674(18)31561-7.Cell.Available online 25 October 2018.Cell.2018 Sep 27. pii: S0092-8674(18)31183-8.Cell.2018 Jun 28;174(1):172-186.e21.Cell.2018 Feb 22;172(5):1007-1021.e17.Cell.2017 Nov 30;171(6):1284-1300.e21.Cell.2017 Aug 17. pii: S0092-8674(17)30869-3.Cell.2017 Jul 13;170(2):312-323Nat Med.2018 Jan 29.Nat Med.2017 Nov;23(11):1342-1351.Cell.2017 Apr 6;169(2):286-300.Cell.2015 Aug 27;162(5):987-1002.Cell.2015 Feb 12;160(4):729-44.Nature Medicine.2017 Apr;23(4):493-500.Cancer Cell.2018 May 14;33(5):905-921.e5.Cancer Cell.2018 Apr 9;33(4):752-769.e8.Cancer Cell.2018 Mar 12;33(3):401-416.e8.Cancer Cell.2017 Aug 14;32(2):253-267.e5.Nat Methods.2018 Jul;15(7):523-526.Cell Stem Cell.2018 May 3;22(5):769-778.e4.Cell Stem Cell.2017 Nov 20. pii: S1934-5909(17)30375-2.Quality Control & MSDS
- View current batch:
- Purity = 98.00%
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet
Chemical structure
Fucoidan Dilution Calculator
calculate
Fucoidan Molarity Calculator
calculate
| Cas No. | 9072-19-9 | SDF | Download SDF |
| Synonyms | Fucan,Sulfated α-L-Fucan | ||
| Chemical Name | (2S,3S,4S,5S,6R)-4-hydroxy-5-methoxy-2,6-dimethyltetrahydro-2H-pyran-3-yl hydrogen sulfate | ||
| Canonical SMILES | C[C@]1([H])[C@@H](OC)[C@H](O)[C@H](OS(O)(=O)=O)[C@H](C)O1 | ||
| Formula | (C6H9O3SO3)n | M.Wt | N/A |
| Solubility | ≤1mg/ml in PBS(pH7.2) | Storage | Store at -20°C |
| Physical Appearance | A crystalline solid | Shipping Condition | Evaluation sample solution : ship with blue ice.All other available size:ship with RT , or blue ice upon request |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. | ||
Fucoidan, a type of complex carbohydrate called a polysaccrharide, is found in many forms of brown seaweed. Fucoidan has a variety of biological activities, including anticancer, antiviral, neuroprotective, and immune-modulating effects. It has been reported that fucoidan enhances the activities of natural killer (NK) cells which play a vital role in anti-cancer activity.
In vitro: Fucoidan triggered apoptosis of PC-3 cells, human prostate cancer cells, via evoking intrinsic and extrinsic signaling pathways in a dose-dependent fashion, which indicated that fucoidan could dose-dependently block the growth of PC-3 cells. The activation of apoptosis induced by fucoidan was involved in the inactivation of p38 MAPK and phosphatidylinositol 3-kinase (PI3K) /Akt, and the activation of extracellular signal-regulated kinase mitogen-activated protein kinase (ERK1/2 MAPK) [1].
In vivo: Female Balb/c mice bearing breast cancer were intraperitoneally injected with fucoidan at 10 mg/kg body weight every two days for 20 days. Fucoidan decreased the tumor volume and the tumor weight in Balb/c mice. Additionally, fucoidan triggered apoptosis, which indicated that fucoidan could exert a strong antitumor effect on breast cancer model. Compared with control group, fucoidan dampened angiogenesis in tumor tissue via inducing a remarkable decrease in intratumoral vascular endothelial growth factor expression and inhibited lung metastasis of breast cancer [2].
References:[1]. Boo, H., Hong, J., Kim, S., Kang, J., Kim, M., & Kim, E. et al. The Anticancer Effect of Fucoidan in PC-3 Prostate Cancer Cells. Marine Drugs. 2013; 11(8): 2982-2999. [2]. Xue, M., Ge, Y., Zhang, J., Wang, Q., Hou, L., & Liu, Y. et al. Anticancer Properties and Mechanisms of Fucoidan on Mouse Breast Cancer In Vitro and In Vivo. Plos ONE. 2012; 7(8). e43483.
